Vialwirebiotech, curated
October 2, 2026, 5:01 AM
June 16, 2026
- 5:00 AM · Drug Discovery World5:00 AMA potentially practice-changing advance in bile duct cancer — Drug Discovery World
- 4:42 AM · Pharmaceutical Technology4:42 AMALK’s EURneffy secures MHRA approval for anaphylaxis treatment — Pharmaceutical Technology
June 15, 2026
- 8:00 PM · Nature Biotechnology8:00 PMDeepMind spinout raises $2.1 billion — Nature Biotechnology
- 4:15 PM · Nikkei Asia4:15 PMJapan's Eisai to pump $64m into UK plant to package injectable drugs — Nikkei Asia
- 2:57 PM · Pharmaceutical Technology2:57 PMEHA26: Epcoritamab improves PFS but not OS in R/R LBCL — Pharmaceutical Technology
- 12:00 PM · BioWorld12:00 PMProposed CMS rule aims to close fixed combo drug loophole — BioWorld
- 12:00 PM · BioWorld12:00 PMNo CNPV needed? Sanofi’s Tzield gains accelerated nod in stage 3 T1D — BioWorld
- 11:25 AM · STAT News
- 9:43 AM · BioPharma Dive9:43 AMLilly scores early positive data for new JAK drug — BioPharma Dive
- 9:40 AM · Drug Discovery World9:40 AMJAK inhibitor for VEXAS syndrome gets orphan drug designations — Drug Discovery World
- 9:00 AM · BioWorld9:00 AMMicrobiota modulates the antidepressant effects of GLP-1 analogues — BioWorld
- 8:30 AM · Bloomberg — Technology8:30 AMActivist Investor Ananym Urges Bio-Techne to Consider Selling — Bloomberg — Technology
- 8:00 AM · Bloomberg — Technology8:00 AMPrime Radiant Invests $50 Million in Cellares Before 2027 IPO — Bloomberg — Technology
- 6:28 AM · Pharmaceutical Technology6:28 AMYounger UK children to benefit from new dose of nasal spray allergy drug — Pharmaceutical Technology
- 5:00 AM · Pharmaceutical Technology5:00 AMSimcere and Stanford partner to develop IPF therapies — Pharmaceutical Technology
- 5:00 AM · Drug Discovery World5:00 AMOriva appoints Arbat as CEO, advances endometriosis asset — Drug Discovery World
- 3:39 AM · Pharmaceutical Technology3:39 AMFDA clears MSD’s Keytruda combo plus Welireg for ccRCC treatment — Pharmaceutical Technology
June 14, 2026
- 6:00 AM · The Guardian — Science6:00 AMLondon startup to trial drug to prevent cancer therapy side-effect ‘cytokine storm’ — The Guardian — Science